SANA
Sana Biotechnology, Inc. · Healthcare · Biotechnology
Momentum-Eingaben (vergleichbare Manager):
Halterbreite -8.3% ·
Aktienfluss -1.7% ·
neue Nettopositionen -9.1%
— Formel
Breite Distribution — sinkende Anteile und weniger Halter
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q1 2025
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q2 2026 | 85 | +4 | 119.01M | $415.23M | +9 | −5 |
| Q1 2026 | 84 | -3 | 118.01M | $339.95M | +3 | −6 |
| Q4 2025 | 87 | +2 | 116.35M | $473.54M | +2 | — |
| Q3 2025 | 15 | -2 | 97.26M | $345.27M | — | −2 |
| Q2 2025 | 14 | 0 | 77.71M | $212.16M | +2 | −2 |
| Q1 2025 | 11 | -1 | 31.65M | $53.17M | +1 | −2 |
| Q4 2024 | 12 | -1 | 32.20M | $52.48M | +1 | −2 |
| Q3 2024 | 12 | +2 | 22.88M | $95.19M | +2 | — |
| Q2 2024 | 10 | — | 23.15M | $126.39M | — | — |
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Baillie Gifford ✦ | 10.19M | -0.4% | $17.12M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 2 | Baillie Gifford ✦ | 10.19M | -0.4% | $17.12M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 3 | Baillie Gifford ✦ | 10.19M | -0.4% | $17.12M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 4 | Baillie Gifford ✦ | 10.19M | -0.4% | $17.12M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 5 | State Street Global Advisors ✦ (passiv) | 5.49M | -18.1% | $9.23M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 6 | Capital World Investors ✦ | 5.45M | 0.0% | $9.15M | 0.0% | Held | 4 | SEC ↗ |
| 7 | Citadel Advisors ✦ | 3.40M | +182.2% | $5.72M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 8 | Geode Capital Management ✦ (passiv) | 3.28M | +2.6% | $5.50M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 9 | Geode Capital Management ✦ (passiv) | 3.28M | +2.6% | $5.50M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 10 | T. Rowe Price ✦ | 2.65M | -14.6% | $4.46M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 11 | T. Rowe Price ✦ | 2.65M | -14.6% | $4.46M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 573.15K | +49.8% | $962,887 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 573.15K | +49.8% | $962,887 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 573.15K | +49.8% | $962,887 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 573.15K | +49.8% | $962,887 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 573.15K | +49.8% | $962,887 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 17 | Millennium Management ✦ | 237.13K | -67.5% | $398,377 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 18 | Marshall Wace ✦ | 211.23K | +890.6% | $354,861 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 19 | Marshall Wace ✦ | 211.23K | +890.6% | $354,861 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 20 | Two Sigma Investments ✦ | 107.49K | -77.6% | $180,576 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 21 | D. E. Shaw & Co. ✦ | 51.96K | Neu | $87,296 | 0.0% | New | 1 | SEC ↗ |
„Ihre Gewichtung" = Anteil der Position am gemeldeten 13F-Eigenkapitalwert des jeweiligen Managers — das Conviction-Maß. ✦ = kuratorisch ausgewählter Manager.
Neue Käufer
| D. E. Shaw & Co. | $87,296 | 0.0% |
Ausgestiegen
| Point72 Asset Management | $592,697 | war 0.0% |
| Renaissance Technologies | $521,303 | war 0.0% |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 199 Inhaber, 163.30M Anteile, $468.43M gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten — Zählungen gemeinsamer Eigentümerschaft, keine fundamentalen Zusammenhänge.